UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

Journal of the American College of Cardiology, 2011-01, Vol.57 (3), p.313-321

2011

Volltextzugriff (PDF)

Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation

The American heart journal, 2007-06, Vol.153 (6), p.1006-1012

2007

Volltextzugriff (PDF)

“Pill in the Pocket” Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation

The American journal of cardiology, 2021-02, Vol.140, p.55-61

2021

Volltextzugriff (PDF)

Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter

Journal of cardiovascular electrophysiology, 2012-05, Vol.23 (5), p.462-472

2012

Volltextzugriff (PDF)

Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis

International journal of cardiology, 2017-01, Vol.227, p.284-291

2017

Volltextzugriff (PDF)

Metoprolol for atrial fibrillation: state of the art

Giornale italiano di cardiologia (2006), 2022-06, Vol.23 (6), p.419

2022

Volltextzugriff (PDF)

Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation

Europace (London, England), 2016-11, Vol.18 (11), p.1698-1704

2016

Volltextzugriff (PDF)

The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker

The American heart journal, 2008-08, Vol.156 (2), p.373.e1-373.e8

2008

Volltextzugriff (PDF)

Safety of Flecainide

Drug safety, 2012-04, Vol.35 (4), p.273-289

2012

Volltextzugriff (PDF)

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Europace (London, England), 2011-02, Vol.13 (2), p.161-173

2011

Volltextzugriff (PDF)

Antiarrhythmic drugs for atrial fibrillation

Expert opinion on pharmacotherapy, 2011-06, Vol.12 (8), p.1201-1215

2011

Volltextzugriff (PDF)

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation

Europace (London, England), 2019-12, Vol.21 (12), p.1764-1775

2019

Volltextzugriff (PDF)

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

The American journal of cardiology, 1994-09, Vol.74 (5), p.503-505

1994

Volltextzugriff (PDF)

The ROCKET AF study

Giornale italiano di cardiologia (2006), 2012-09, Vol.13 (9), p.553

2012

Volltextzugriff (PDF)

Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey

European heart journal, 2008-03, Vol.29 (5), p.632-639

2008

Volltextzugriff (PDF)

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

International journal of cardiology, 1994-03, Vol.43 (3), p.305-313

1994

Volltextzugriff (PDF)

Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation: Results of the Euro Heart Survey on Atrial Fibrillation

Journal of the American College of Cardiology, 2009-05, Vol.53 (18), p.1690-1698

2009

Volltextzugriff (PDF)

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment

Heart (British Cardiac Society), 2010-04, Vol.96 (7), p.546-549

2010

Volltextzugriff (PDF)

The BRIDGE study

Giornale italiano di cardiologia (2006), 2016-01, Vol.17 (1), p.1

2016

Volltextzugriff (PDF)

Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis

Expert review of cardiovascular therapy, 2014-09, Vol.12 (9), p.1067-1075

2014

Volltextzugriff (PDF)

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens

International journal of cardiology, 1997-01, Vol.58 (1), p.55-61

1997

Volltextzugriff (PDF)

The AVRO study

Giornale italiano di cardiologia (2006), 2011-11, Vol.12 (11), p.693

2011

Volltextzugriff (PDF)

New anthyarrhythmic drugs for atrial fibrillation

Future cardiology, 2015-11, Vol.11 (6), p.705-717

2015

Volltextzugriff (PDF)

Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?

Annals of noninvasive electrocardiology, 2013-01, Vol.18 (1), p.12-20

2013

Volltextzugriff (PDF)

Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life

Europace (London, England), 2010-05, Vol.12 (5), p.634-642

2010

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaAtrial Fibrillation - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(41)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation

“Pill in the Pocket” Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation

Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter

Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis

Metoprolol for atrial fibrillation: state of the art

Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation

The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker

Safety of Flecainide

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Antiarrhythmic drugs for atrial fibrillation

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

The ROCKET AF study

Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation: Results of the Euro Heart Survey on Atrial Fibrillation

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment

The BRIDGE study

Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens

The AVRO study

New anthyarrhythmic drugs for atrial fibrillation

Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?

Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life

Aktive Filter

Suchergebnisse filtern